Understand the source comparison
Selank Amidate Focus Results Timeline Expect: Administration Protocol Comparison
Intranasal 300mcg once daily 3–5 days 18–24 days 4–6 hours post-dose Slower accumulation. Adequate for mild stress; suboptimal for sustained focus under cognitive load Intranasal 300mcg twice daily (AM/PM) 2–4 days 14–18 days 8–10 hours coverage Standard resea
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Intranasal 300mcg once daily
- 3–5 days
- 18–24 days
- 4–6 hours post-dose
- Slower accumulation. Adequate for mild stress; suboptimal for sustained focus under cognitive load
- Intranasal 300mcg twice daily (AM/PM)
- 2–4 days
- 14–18 days
- 8–10 hours coverage
- Standard research protocol. Balanced receptor occupancy; peak BDNF response by week three
- Intranasal 600mcg once daily
- 2–3 days
- 16–21 days
- 6–8 hours post-dose
- Faster anxiolytic onset; no acceleration of neuroplastic timeline; higher dose doesn't compress BDNF maturation
- Subcutaneous 500mcg every 48 hours
- 4–6 days
- 21–28 days
- Sustained plasma levels
- Alternative route; slower subjective onset; equivalent long-term neuroplasticity if maintained consistently
- The comparison underscores that cognitive enhancement timelines cannot be compressed through higher dosing. BDNF transcription and synaptic remodeling operate on biological schedules that doses above threshold do not accelerate.